ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
Home
Press release
Dec 25, 2020 14:00 JST
Source:
Showa Denko K.K.
Showa Denko Revises Dividend Payment Forecast
TOKYO, Dec 25, 2020 - (JCN Newswire) - Showa Denko (SDK; TSE:4004) announces that it revises its forecast of year-end dividend payment as in below, taking the latest trend in its business performance into consideration.
1. Reasons for the revision of dividend payment forecast
Based on its comprehensive consideration to the importance of the maintenance of shareholder return, including stable payment of dividend, and its latest forecast of the performance for 2020, SDK revises its forecast of year-end dividend payment per share as in below.
2. Revised forecast of dividend payment
Dividend per share (Unit: yen) End of 2Q / Year end / Total
Earlier forecast (Announced on August 12, 2020) : - / Undecided / Undecided
Revised forecast (Announced on December 25, 2020) : - / 65.00 / 65.00
Actual dividends for 2020 : 0.00 / - / -
Actual dividends for 2019 : 50.00 / 80.00 / 130.00
About Showa Denko K.K.
Showa Denko K.K. (SDK; TSE:4004, ADR:SHWDY) is a major manufacturer of chemical products serving from heavy industry to computers and electronics. The Petrochemicals Sector provides cracker products such as ethylene and propylene, the Chemicals Sector provides industrial, high-performance and high-purity gases and chemicals for semicon and other industries, the Inorganics Sector provides ceramic products, such as alumina, abrasives, refractory/graphite electrodes and fine carbon products. The Aluminum Sector provides aluminum materials and high-value-added fabricated aluminum, the Electronics Sector provides HD media, compound semiconductors such as ultra high bright LEDs, and rare earth magnetic alloys, and the Advanced Battery Materials Department (ABM) provides lithium-ion battery components. For more information, please visit www.sdk.co.jp/english/.
Contact:
Showa Denko K.K., CSR & Corporate Communication Office, Tel: 81-3-5470-3235
Source: Showa Denko K.K.
Sectors: Chemicals
Copyright ©2021 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
Eisai and National Cancer Center Commence Joint Research and Development Project
May 14, 2021 17:48 JST
TOYOTA GAZOO Racing Leads the WRC onto Gravel
May 14, 2021 17:04 JST
Hitachi ABB Power Grids enables Minnesota Power to deliver more clean and affordable hydropower to the U.S. Upper Midwest region
May 14, 2021 15:24 JST
NEC X and Alchemist Accelerator Announce Partnership to Speed Successful Startup Launches
May 14, 2021 14:02 JST
Mitsubishi Power Achieves #1 Market Share Globally in the First Quarter of 2021 According to McCoy Power Report
May 13, 2021 18:29 JST
Showa Denko Announces 2021 First Quarter Financial Results
May 13, 2021 15:30 JST
Mitsubishi Shipbuilding Holds Christening and Launch Ceremony in Shimonoseki for Large Ferry Built for Meimon Taiyo Ferry
May 13, 2021 15:06 JST
MHI Thermal Systems fully revises a lineup of inverter multi-split air conditioners for buildings in its overseas markets
May 13, 2021 14:06 JST
MHI Thermal Systems Confirms Effectiveness of Air Purification Filtering Technology for Removal and Inactivation of SARS-CoV-2
May 12, 2021 12:17 JST
Collaboration with South Pole to Generate and Sell Carbon Credits from Carbon Removal Technologies
May 12, 2021 12:02 JST
Fujitsu Signs Strategic Collaboration Agreement with AWS to Accelerate Digital Transformation in the Mobility Industry
May 12, 2021 10:51 JST
Mitsubishi Power Receives Turnkey Order for 50MW Woody Biomass-fired Power Generation Facility
May 11, 2021 18:39 JST
Eisai's Statement of Commitment for Carbon Neutrality by 2040
May 11, 2021 10:00 JST
ENEOS and Toyota Come Together to Make Woven City the Most Hydrogen-Based Society
May 10, 2021 15:38 JST
Showa Denko Revises Forecast of Consolidated Performance and to Record Extraordinary Loss
May 10, 2021 11:30 JST
Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Priority Review From FDA for LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Applications
May 07, 2021 11:08 JST
Showa Denko and Infineon Technologies Conclude Supply Contract and Development Agreement
May 06, 2021 17:30 JST
NEC Develops Neuroscience-inspired AI Technology for Time Series Analysis
May 06, 2021 14:13 JST
NEC Contributes to Development of Artificial DNA Aptamer that Binds to the Novel Coronavirus (SARS-CoV-2)
May 06, 2021 11:27 JST
Synopsis 2021: Hot Trends - Join the Summit 1-5 June
May 04, 2021 09:00 JST
More Latest Release >>
Related Release
Showa Denko Announces 2021 First Quarter Financial Results
May 13 2021 14:30 JST
Showa Denko Revises Forecast of Consolidated Performance and to Record Extraordinary Loss
May 10 2021 10:30 JST
Showa Denko and Infineon Technologies Conclude Supply Contract and Development Agreement
May 06 2021 16:30 JST
Showa Denko Announces Share Transfer with Change in Subsidiary
April 16 2021 15:30 JST
Showa Denko CEO Message to Newly-hired Employees
April 02 2021 06:00 JST
SDK Announces 2020 Consolidated Financial Results
February 17 2021 15:00 JST
Showa Denko K.K. Announces Execution of Master Agreement regarding Series of Transactions
January 28 2021 16:00 JST
SDK to increase capacity of aluminum substrate for hard disks
January 15 2021 09:00 JST
New Year Message from Kohei Morikawa, Showa Denko President and CEO
January 04 2021 13:00 JST
DENSO Adopts SDK SiC Epi-wafers for Next-Generation Booster Power Modules for FCEVs
December 10 2020 14:00 JST
More Press release >>